GSK3β negatively regulates HIF1α mRNA stability via nucleolin in the MG63 osteosarcoma cell line

Biochemical and Biophysical Research Communications

Volumn 443, Issue 2, 2014, Pages 598-603

  Cheng, Dong Dong ^a   Zhao, Hai Guang ^b   Yang, Yun Song ^c   Hu, Tu ^a   Yang, Qing Cheng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

GSK3 ; HIF1 ; mRNA; Nucleolin; Osteosarcoma

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; NUCLEOLIN;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE TARGETING; LUCIFERASE ASSAY; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA INTERFERENCE; WESTERN BLOTTING;

ARNT; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CHX; CYCLOHEXIMIDE; EPO; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 1; GLUT1; GLYCOGEN SYNTHASE KINASE 3 BETA; GSK3Β; HIF1Α; HYPOXIA-INDUCIBLE FACTOR 1Α; MRNA; NUCLEOLIN; ODD; OSTEOSARCOMA; OXYGEN-DEPENDENT DEGRADATION; SDS-PAGE; SIRNA; SMALL INTERFERING RNA; SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF; VHL; VON HIPPEL-LINDAU;

CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OSTEOSARCOMA; PHOSPHOPROTEINS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84892442493     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.020     Document Type: Article

References (32)

1. D.J. Manalo, A. Rowan, and T. Lavoie et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1 Blood 105 2005 659 669
2. K. Hirota, and G.L. Semenza Regulation of angiogenesis by hypoxia-inducible factor 1 Crit. Rev. Oncol. Hematol. 59 2006 15 26
3. R.H. Wenger, D.P. Stiehl, and G. Camenisch Integration of oxygen signaling at the consensus HRE Sci. STKE 2005 2005 re12
4. G.L. Semenza Hypoxia-inducible factor 1: master regulator of O2 homeostasis Curr. Opin. Genet. Dev. 8 1998 588 594
5. G.L. Wang, B.H. Jiang, E.A. Rue, and G.L. Semenza Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension Proc. Natl. Acad. Sci. U.S.A. 92 1995 5510 5514
6. S. Salceda, and J. Caro Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes J. Biol. Chem. 272 1997 22642 22647
7. M. Ivan, K. Kondo, and H. Yang et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing Science 292 2001 464 468
8. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein EMBO J. 19 2000 4298 4309
9. D. Flügel, A. Görlach, and T. Kietzmann GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α Blood 119 2012 1292 1301
10. N. Embi, D.B. Rylatt, and P. Cohen Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase Eur. J. Biochem. 107 1980 519 527
11. J.R. Woodgett Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO J. 9 1990 2431 2438
12. T. Kang, Y. Wei, and Y. Honaker et al. GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers Cancer Cell 13 2008 36 47
13. Y. Yin, N.T. Kizer, and P.H. Thaker et al. Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer Int. J. Mol. Sci. 14 2013 16617 16637
14. G. Manning, D.B. Whyte, and R. Martinez et al. The protein kinase complement of the human genome Science 298 2002 1912 1934
15. B.W. Doble, and J.R. Woodgett GSK-3: tricks of the trade for a multi-tasking kinase J. Cell Sci. 116 2003 1175 1186
16. R. Mishra Glycogen synthase kinase 3 beta: can it be a target for oral cancer Mol. Cancer 9 2010 144
17. H.T. Wu, S.Y. Ko, and J.H. Fong et al. Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation J. Oral Pathol. Med. 38 2009 206 213
18. A. Iamaroon, and S. Krisanaprakornkit Overexpression and activation of Akt2 protein in oral squamous cell carcinoma Oral Oncol. 45 2009 e175 e179
19. D. Flügel, A. Görlach, C. Michiels, and T. Kietzmann Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner Mol. Cell. Biol. 27 2007 3253 3265
20. X. Kong, B. Alvarez-Castelao, and Z. Lin et al. Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein J. Biol. Chem. 282 2007 15498 15505
21. E. Minet, I. Ernest, and G. Michel et al. HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5′UTR Biochem. Biophys. Res. Commun. 261 1999 534 540
22. D. Zhang, J. Li, and M. Zhang et al. The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability J. Biol. Chem. 287 2012 34361 34371
23. H. Sun, X.B. Li, and Y. Meng et al. TRAF6 upregulates expression of HIF-1α and promotes tumor angiogenesis Cancer Res. 73 2013 4950 4959
24. I.J. Yeh, N. Ogba, H. Bensigner et al., HEXIM1 downregulates Hypoxia Inducible Factor-1 alpha protein stability, Biochem. J. (2013) Sep 10. [Epub ahead of print].
25. B. Marchand, I. Tremblay, and S. Cagnol Boucher MJ, Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms Carcinogenesis 33 2012 529 537
26. E. Gavilán, I. Sánchez-Aguayo, P. Daza, and D. Ruano GSK-3β signaling determines autophagy activation in the breast tumor cell line MCF7 and inclusion formation in the non-tumor cell line MCF10A in response to proteasome inhibition Cell Death Dis. 4 2013 e572
27. S.H. Kao, W.L. Wang, C.Y. Chen et al., GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug, Oncogene (2013) Jul 15. [Epub ahead of print].
28. R. Ma, Y. Wei, and X. Huang et al. Inhibition of GSK 3β activity is associated with excessive EZH2 expression and enhanced tumour invasion in nasopharyngeal carcinoma PLoS ONE 8 2013 e68614
29. J.J. Xia, L.B. Pei, and J.P. Zhuang et al. Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line J. Int. Med. Res. 38 2010 1294 1304
30. S. Storck, M. Shukla, S. Dimitrov, and P. Bouvet Functions of the histone chaperone nucleolin in diseases Subcell. Biochem. 41 2007 125 144
31. M. Takagi, M.J. Absalon, K.G. McLure, and M.B. Kastan Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin Cell 123 2005 49 63
32. V. González, K. Guo, L. Hurley, and D. Sun Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein J. Biol. Chem. 284 2009 23622 23635